One-size MAP does not fit all

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Senussi, Mourad H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIALYSIS FLUID; NORADRENALIN; VASOCONSTRICTOR AGENT;

ACUTE KIDNEY FAILURE; BRAIN ISCHEMIA; CRITICALLY ILL PATIENT; DEATH; HEALTH CARE COST; HEART FAILURE; HUMAN; HYPERTENSION; INCIDENCE; LETTER; MEAN ARTERIAL PRESSURE; MORTALITY; MULTICENTER STUDY (TOPIC); NEW-ONSET ATRIAL FIBRILLATION; ORGAN BLOOD FLOW; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE RISK; RENAL REPLACEMENT THERAPY; RESUSCITATION; SEPSIS; SEPTIC SHOCK; ARTERIAL PRESSURE; DRUG EFFECTS; SHOCK, SEPTIC;

ARTERIAL PRESSURE; HUMANS; NOREPINEPHRINE; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 84928889987     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-0939-0     Document Type: Letter

References (5)

1. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580-637.
2. Leone M, Asfar P, Radermacher P, Vincent J-L, Martin C. Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature. Crit Care. 2015;19:794.
3. Asfar P, Meziani F, Hamel J-F, Grelon F, Megarbane B, Anguel N, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583-93.
4. Walkey AJ, Wiener RS, Ghobrial JM, Curtis LH, Benjamin EJ. Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA. 2011;306:2248-54.
5. Walkey AJ, Hammill BG, Curtis LH, Benjamin EJ. Long-term outcomes following development of new-onset atrial fibrillation during sepsis. Chest. 2014;146:1187-95.